Humanized antibody for CA125 capture in CLIA applications. Recognizes MUC16 macromolecular glycoprotein for diagnosis and disease progression monitoring in epithelial ovarian tumors.
Manufactured by
Shenzhen, Guangdong, China
HeavyBio Inc. is a young expert in IVD raw materials for cardiac markers, tumor markers, inflammatory markers, neuroendocrine and infectious diseases, which has been committed to becoming the world's leading IVD reagent supplier since 2017. Based in Shenzhen, China, the company develops, manufactures and commercializes high-quality monoclonal antibodies, recombinant antibodies, antigens, etc., which are widely used in ELISA, CLIA, latex and rapid test platforms. Innovation and quality are our top priorities, market and customer orientation are our constant endeavors. HeavyBio Inc. has been at the forefront of fighting the Covid-19 pandemic since 2020, thanks to a professional team of more than 60% R D and technical service experts, which has earned a good reputation in the IVD field in China. HeavyBio Inc. is your trusted Chinese IVD solution provider and raw material specialist!
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
J. Mitra & Co. Pvt. Ltd.
India · 1 relevant product
BiosPacific
United States · 6 relevant products
Boditech Med Inc.
South Korea · 3 relevant products
Zhejiang Orient Gene Biotech Co.,Ltd.
China · 1 relevant product
Fujirebio Diagnostics,Inc.
China · 4 relevant products
Nanjing Poclight Biotechnology Co.,Ltd.
China · 2 relevant products
VEDALAB SAS
France · 4 relevant products
Medix Biochemica Oy AB
Finland · 1 relevant product
Labex Canada Inc.
Canada · 7 relevant products
SDIX, LLC
United States · 6 relevant products
15 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →2 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 76 closest product alternatives
J. Mitra & Co. Pvt. Ltd. · India
Tumor marker assay kit for CA19-9 detection using chemiluminescence immunoassay. Analytical sensitivity of 1.50 U/mL with linearity from 1.50 to 1000 U/mL.
BiosPacific · United States
Affinity purified antibodies for CA-125 biomarker detection in cancer diagnostics. Supports immunoassay platforms for ovarian and other cancer monitoring.
Boditech Med Inc. · South Korea
A cancer biomarker reagent useful in aiding the diagnosis of ovarian cancer.
Zhejiang Orient Gene Biotech Co.,Ltd. · China
Immunological test for measurement of cancer antigen 125. Used for diagnosis and monitoring of ovarian cancer.
Fujirebio Diagnostics,Inc. · China
In vitro diagnostic assay for cancer antigen 125 detection in patient samples. The test is used for endometrial cancer evaluation and monitoring of ovarian malignancies.
Nanjing Poclight Biotechnology Co.,Ltd. · China
A homogeneous chemiluminescence immunoassay test kit for quantitative detection of CA125 tumor marker in human serum. Used for oncology screening and monitoring in clinical laboratory settings.
VEDALAB SAS · France
Immunochromatographic rapid test for the quantitative detection of CA 125 (ovarian cancer antigen) in whole blood, serum or plasma. Measuring range: 15-750 U/mL. Reading time: 15 minutes.
VEDALAB SAS · France
Immunochromatographic rapid test for the quantitative detection of CA 125 (ovarian cancer antigen) in whole blood, serum or plasma. Measuring range: 15–750 U/mL. Reading time: 15 minutes.
Medix Biochemica Oy AB · Finland
A diagnostic test for measuring Cancer Antigen 125 (CA125) levels in blood samples. This test is used in clinical laboratories for cancer screening and monitoring.
Fujirebio Diagnostics,Inc. · China
In vitro diagnostic assay measuring HE4 and CA125 biomarkers for evaluation of endometrial-like cancer lymph node metastasis. This combined marker approach provides improved diagnostic accuracy for gynecological malignancies.
Labex Canada Inc. · Canada
Calcium-binding protein antibody active in cell cycle regulation. Distinguishes lung adenocarcinoma from mesothelioma and identifies serous membrane tumors.
Fujirebio Diagnostics,Inc. · China
An in vitro diagnostic test kit for the detection of cancer antigen 125 (CA125), a tumor marker. The product is CE certified and complies with European in vitro diagnostic product directive 98/79/EC. It is manufactured by ISO13485 certified facilities in Gothenburg, Sweden and Malvern, Pennsylvania, USA.
64 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products